Keyphrases
Lung Transplantation
100%
Lung
70%
Asthma
65%
Ventilator-associated Pneumonia
51%
Confidence Interval
44%
Intensive Care Unit
41%
COVID-19
36%
Clinical Outcomes
28%
Airway
27%
Pulmonary Arterial Hypertension
27%
Severe Asthma
26%
Pulmonary Embolism
25%
Chronic Obstructive Pulmonary Disease
24%
Pneumonia
23%
Sepsis
23%
Mechanical Ventilation
23%
Airway Epithelial Cells
22%
Critically Ill Patients
21%
Risk Factors
20%
Hospitalization
19%
Transplantation
19%
Cystic Fibrosis
19%
Hospital Mortality
19%
Antibiotics
19%
Emphysema
19%
Bronchiolitis Obliterans Syndrome
18%
Odds Ratio
18%
Acute Rejection
18%
Forced Expiratory Volume in 1 Second (FEV1)
18%
T Cells
18%
Inflammation
17%
Acute Respiratory Distress Syndrome
17%
Pseudomonas Aeruginosa (P. aeruginosa)
16%
Clinical Trials
16%
United States
16%
Community-acquired Pneumonia
16%
Septic Shock
16%
CD28
15%
Macrophages
15%
Lung Volume Reduction Surgery
15%
Pulmonary Hypertension
15%
Methicillin-resistant Staphylococcus Aureus
15%
Placebo
14%
Adjusted Odds Ratio
14%
High Risk
14%
Emergency Department
14%
Mechanically Ventilated Patients
13%
Epithelial Cells
13%
Nosocomial Pneumonia
13%
Acute Pulmonary Embolism
13%
Gene Expression
13%
Lung Function
13%
Neutrophils
13%
Symptomatic Pulmonary Embolism
13%
Antimicrobial Therapy
13%
Patient Outcomes
12%
Acute Symptoms
12%
Severe Sepsis
12%
Virus
12%
Idiopathic Pulmonary Fibrosis
12%
Randomized Controlled Trial
12%
Hospitalized Patients
11%
Immune Response
11%
Mouse Model
11%
Retrospective Cohort Study
11%
Surgical Intensive Care Unit
10%
Bronchial Thermoplasty
10%
Meta-analysis
10%
Epidemiology
10%
Disease Severity
10%
Chronic Lung Allograft Dysfunction
10%
Respiratory Viral Infection
10%
Healthcare-associated Pneumonia
10%
Bronchoscopy
10%
Acute Lung Injury
10%
Severe Asthma Research Program
10%
Length of Hospital Stay
10%
Inhaled Corticosteroids
10%
Human Lung
9%
Adult Patients
9%
Asthma Control
9%
Viral Infection
9%
Quality of Life
9%
Autophagy
9%
Randomized Trial
9%
Bloodstream Infection
9%
Asthmatic
9%
Nosocomial Infection
9%
FOXJ1
9%
Bronchoalveolar Lavage
9%
Airway Disease
9%
Airway Inflammation
8%
All-cause Mortality
8%
Innate Immune Response
8%
Critical Care
8%
Jewish
8%
Interleukin-13 (IL-13)
8%
Primary Graft Dysfunction
8%
Antibody-mediated Rejection
8%
Computed Tomography
8%
Medicine and Dentistry
Lung
99%
Lung Transplantation
85%
Asthma
47%
Infection
43%
Intensive Care Unit
36%
Disease
36%
COVID-19
31%
Pulmonary Embolism
31%
Pulmonary Hypertension
28%
Ventilator-Associated Pneumonia
25%
Epithelial Cell
24%
Sepsis
23%
Chronic Obstructive Pulmonary Disease
23%
Artificial Respiration
21%
Diagnosis
20%
Odds Ratio
20%
Emphysema
19%
Pathogen
18%
Pneumonectomy
16%
Allograft
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Bronchiolitis Obliterans
15%
Transplantation
14%
Cystic Fibrosis
14%
Antibiotics
13%
Bronchoscopy
13%
Intensive Care
13%
Hospital Mortality
12%
Placebo
12%
Quality of Life
12%
Severe Asthma
12%
Acute Pulmonary Embolism
12%
Clinical Trial
12%
Emergency Department
11%
Cohort Analysis
11%
Antibiotic Therapy
11%
Septic Shock
11%
Health Care Cost
11%
Silo-Filler's Disease
11%
Acute Respiratory Distress Syndrome
10%
Clinician
10%
Biopsy Technique
10%
Acute Graft Rejection
10%
Bronchial Thermoplasty
10%
Adverse Event
10%
Bloodstream Infection
10%
Antiinfective Agent
9%
Antibiotic Resistance
9%
Randomized Controlled Trial
9%
Endobronchial Ultrasonography
9%
Retrospective Cohort Study
8%
Cohort Effect
8%
Macrophage
8%
Idiopathic Pulmonary Fibrosis
8%
Forced Expiratory Volume
8%
Respiratory Disease
8%
Immune Response
8%
Prevalence
7%
In Vitro
7%
T Cell
7%
Computer Assisted Tomography
7%
Heart Transplantation
7%
Combination Therapy
7%
Antibody Mediated Rejection
7%
Chronic Graft Rejection
7%
Dyspnea
7%
Immunity
7%
Antimicrobial Therapy
7%
Community-Acquired Pneumonia
7%
Hospital-Acquired Pneumonia
7%
Methicillin Resistant Staphylococcus Aureus
7%
Biological Marker
7%
Lung Volume
7%
Injury
7%
Patient with Asthma
6%
Meta-Analysis
6%
Logistic Regression Analysis
6%
Immunosuppressive Treatment
6%
All Cause Mortality
6%
Lung Nodule
6%
Health Care
6%
Endothelial Cell
6%
Health Care Associated Pneumonia
6%
Risk Stratification
6%
Pseudomonas aeruginosa
6%
Hazard Ratio
6%
Systematic Review
6%
Primary Graft Dysfunction
6%
Comorbidity
6%
Acute Lung Injury
6%
Receptor
6%
Peripheral Lung Lesion
6%
Hospital Infection
5%
Lung Graft Rejection
5%
Outpatient
5%
Mortality Rate
5%
Drug Therapy
5%
Meropenem
5%
Venous Thromboembolism
5%
Lung Lavage
5%